Clinical Trial Update: Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dexmedetomidine as an adjuvant to bupivacaine for ultrasound-guided infraorbital nerve block in cleft lip repair has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cleft Lip

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mansoura University | Conditions: Cleft Lip | Phase 4 | Status: COMPLETED